Biomunex Pharmaceuticals Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
8

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.48M
- Investors
-
5
Biomunex Pharmaceuticals General Information
Description
Developer of immunotherapies designed to deliver therapeutics in the area of immuno-oncology. The company's immunotherapies offer to develop drug candidates with high anti-tumor potential, superior manufacturability, and optimal drug-like properties, enabling biotechnology companies to format antibodies from any pair of monospecific monoclonal antibodies as building blocks in a timely and cost-effective manner.
Contact Information
Website
www.biomunex.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 14 avenue d'Eylau
- 75116 Paris
- France
Biomunex Pharmaceuticals Timeline
Biomunex Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Grant | 03-Nov-2021 | $3.48M | 00.000 | Completed | Generating Revenue | |
5. Later Stage VC (Series A) | 16-Feb-2021 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
4. Seed Round | Completed | Startup | ||||
3. Accelerator/Incubator | Completed | Startup | ||||
2. Grant | 01-Jan-2016 | Completed | Startup | |||
1. Grant | 01-Jan-2014 | Completed | Startup |
Biomunex Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 000,000 | 00.000000 | 000.0 | 000.0 | 00 | 000.0 | 00.00 |
Biomunex Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of immunotherapies designed to deliver therapeutics in the area of immuno-oncology. The company's immunotherap
Drug Discovery
Paris, France
8
As of 2022
00.000
0000000000
00.000
Biomunex Pharmaceuticals Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
G1 Therapeutics | Formerly VC-backed | Durham, NC | 000 | 00000 | 000000 - 000 | 00000 |
000 000000000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 00000000000 | 0000 |
00000000 | Venture Capital-Backed | Boston, MA | 00 | 0000 | 00000000000 | 0000 |
0000000 000000 | Venture Capital-Backed | Barcelona, Spain | 00 | 0000 | 000000000000 | 0000 |
0000000-00000 0000 | Corporation | New York, NY | 00000 | 00000 | 000000000 | 00000 |
Biomunex Pharmaceuticals Patents
Biomunex Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3565847-A1 | A polypeptide linker for preparing multispecific antibodies | Pending | 09-Jan-2017 | 0000000000 | |
CA-3052084-A1 | A polypeptide linker for preparing multispecific antibodies | Pending | 09-Jan-2017 | 0000000000 | |
JP-2020503873-A | Polypeptide linkers for preparing multispecific antibodies | Pending | 09-Jan-2017 | 0000000000 | 00 |
AU-2018206229-A1 | A polypeptide linker for preparing multispecific antibodies | Pending | 09-Jan-2017 | 0000000000 | |
US-20190330377-A1 | A polypeptide linker for preparing multispecific antibodies | Pending | 09-Jan-2017 | C07K16/468 |
Biomunex Pharmaceuticals Executive Team (6)
Biomunex Pharmaceuticals Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Alain Dublin | Self | Board Member | 000 0000 |
C. Grace Yeh | Onward Therapeutics | Board Member | 000 0000 |
Dragan Grabulovski Ph.D | Self | Board Observer | 000 0000 |
Eugene Zhukovsky Ph.D | Biomunex Pharmaceuticals | Chief Technology Officer & Board Member | 000 0000 |
Jordi Esclusa | Self | Board Member | 000 0000 |
Biomunex Pharmaceuticals Signals
Biomunex Pharmaceuticals Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
French Government | Government | Minority | 000 0000 | 000000 0 | |
Onward Therapeutics | Corporation | Minority | 000 0000 | 000000 0 | |
L'Agence Nationale de la Recherche | Government | 000 0000 | 000000 0 | ||
Bpifrance | Sovereign Wealth Fund | 000 0000 | 000000 0 | ||
Agoranov | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |